SECTION 1. Chapter 32A of the General Laws, as appearing in the 2018 Official Edition, is hereby amended by inserting after section 17Q the following section:-
Section 17R. Any coverage offered by the commission to an active or retired employee of the commonwealth insured under the group insurance commission shall provide coverage for the appropriate weight-based dosage of epinephrine injectors. The benefits in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other benefit provided by the commission. For purposes of this section the term “epinephrine injector” shall mean an auto-injector approved by the federal Food and Drug Administration for the administration of epinephrine and a pre-filled syringe approved by the federal Food and Drug Administration and used for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector.
SECTION 2. Chapter 118E of the General Laws is hereby amended by inserting after section 10L the following section:-
Section 10M. The division and its contracted health insurers, health plans, health maintenance organizations, behavioral health management firms and third-party administrators under contract to a Medicaid managed care organization or primary care clinician plan shall provide coverage for the appropriate weight-based dosage of epinephrine injectors. An epinephrine injector prescribed in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other prescribed drugs provided by the division. For purposes of this section the term “epinephrine injector” shall mean an auto-injector approved by the federal Food and Drug Administration for the administration of epinephrine and a pre-filled syringe approved by the federal Food and Drug Administration and used for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector.
SECTION 3. Chapter 175 of the General Laws is hereby amended by inserting after section 47KK the following section:-
Section 47LL. Any individual policy of accident or sickness insurance issued pursuant to this chapter shall provide coverage for the appropriate weight-based dosage of epinephrine injectors. An epinephrine injector prescribed in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other prescribed drug provided by the insurer. For purposes of this section the term “epinephrine injector” shall mean an auto-injector approved by the federal Food and Drug Administration for the administration of epinephrine and a pre-filled syringe approved by the federal Food and Drug Administration and used for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector.
SECTION 4. Chapter 176A of the General Laws is hereby amended by inserting after section 8MM the following section:-
Section 8NN. Any contract between a subscriber and the corporation under an individual group or hospital service plan that is delivered, issued or renewed within the commonwealth shall provide coverage for the appropriate weight-based dosage of epinephrine injectors. An epinephrine injector prescribed in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other prescribed drug provided by the insurer. For purposes of this section the term “epinephrine injector” shall mean an auto-injector approved by the federal Food and Drug Administration for the administration of epinephrine and a pre-filled syringe approved by the federal Food and Drug Administration and used for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector.
SECTION 5. Chapter 176B of the General Laws is hereby amended by inserting after section 4MM the following section:-
Section 4NN. Any subscription certificate under an individual or group medical service agreement delivered, issued or renewed within the commonwealth shall provide coverage for the appropriate weight-based dosage of epinephrine injectors. An epinephrine injector prescribed in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other prescribed drug provided by the insurer. For purposes of this section the term “epinephrine injector” shall mean an auto-injector approved by the federal Food and Drug Administration for the administration of epinephrine and a pre-filled syringe approved by the federal Food and Drug Administration and used for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector.
SECTION 6. Chapter 176G of the General Laws is hereby amended by inserting after section 4EE the following section:-
Section 4FF. Any individual or group health maintenance contract shall provide coverage for the appropriate weight-based dosage of epinephrine injectors. An epinephrine injector prescribed in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other prescribed drug provided by the commission. For purposes of this section the term “epinephrine injector” shall mean an auto-injector approved by the federal Food and Drug Administration for the administration of epinephrine and a pre-filled syringe approved by the federal Food and Drug Administration and used for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.